PBM Psyence Biomedical Ltd.
$3.40▲ +12.96%
Healthcare
Other
Volume 32.8K
Avg Volume (10D) 58.6K
Key Metrics & Fundamentals
Market Cap
$16.10M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.92 - 129.69
% vs 50 MA
-29.85%
% vs 200 MA
-24.06%
RSI-14
34.5
MACD Histogram
-0.1400
Beta (1Y vs SPY)
2.80
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.43M
COGS
–
Operating Exp
$1.51M
Operating Income
-$1.51M
EBIT
-$1.51M
Pretax Income
-$753,254
Net Income
-$753,254
EPS (Diluted)
-3.19
Price & Volume History
Loading chart…
Recent News
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
GlobeNewswire · Oct 21, 2026 7:00 AM ET
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
GlobeNewswire · Oct 5, 2026 7:00 AM ET
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
GlobeNewswire · Sep 28, 2026 7:00 AM ET
Psyence BioMed Announces Strategic Ibogaine Investment
GlobeNewswire · Sep 23, 2026 7:00 AM ET
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
GlobeNewswire · Sep 14, 2026 7:00 AM ET
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
GlobeNewswire · Aug 18, 2026 5:23 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PBM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.